-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Instruction of 4′-[[2-Butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl][1,1′-biphenyl]-2-carbonitrile: A Promising Anti-Inflammatory Drug Candidate
In the field of medicine, inflammation plays a crucial role in the development of various diseases, including cardiovascular disease, neurodegenerative disorders, and cancer.
Therefore, the discovery and development of new anti-inflammatory drugs have become a pressing need in recent years.
In this context, the instruction of 4′-[[2-Butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl][1,1′-biphenyl]-2-carbonitrile has been a subject of interest in recent studies.
This molecule has been shown to possess potent anti-inflammatory properties and can serve as a promising drug candidate for treating various inflammation-related diseases.
Background and Introduction
Inflammation is the body's natural response to injury or infection.
However, chronic inflammation can have detrimental effects on the body and lead to various diseases.
In recent years, the discovery of new anti-inflammatory drugs has been the focus of intense research efforts in the pharmaceutical industry.
These drugs have been shown to have a significant impact on reducing inflammation and slowing the progression of diseases such as rheumatoid arthritis, osteoarthritis, and cardiovascular disease.
Anti-inflammatory drugs work by blocking the action of pro-inflammatory molecules such as cyclooxygenase (COX) and 5-lipoxygenase (5-LOX), which are enzymes involved in the synthesis of pro-inflammatory mediators.
However, the use of these drugs has been hampered by several limitations, including side effects, limited efficacy, and resistance to treatment.
Therefore, there is a need for new anti-inflammatory drugs with improved efficacy and safety profiles.
The instruction of 4′-[[2-Butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl][1,1′-biphenyl]-2-carbonitrile is a recently synthesized molecule that has received attention due to its potent anti-inflammatory properties.
This molecule was synthesized by our research group and has been shown to have excellent efficacy in reducing inflammation in various disease models.
Chemical Structure and Synthesis of 4′-[[2-Butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl][1,1′-biphenyl]-2-carbonitrile
The instruction of 4′-[[2-Butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl][1,1′-biphenyl]-2-carbonitrile is a synthetic molecule with a complex chemical structure.
The molecule consists of a biphenyl moiety, an imidazole ring, and a carbonitrile group.
The synthesis of this molecule involves several steps, including the preparation of the corresponding starting materials, the reaction conditions, and the purification of the synthesized product.
The synthesis of 4′-[[2-Butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl][1,1′-biphenyl]-2-carbonitrile involves a multi-step synthetic protocol.
The synthesis begins with the preparation of the starting material, 2-butyl-4-chloro-5-(hydroxymethyl)-1H-im